EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The inhibitory effects of modified HSJZ decoction on NSCLC by regulating regulatory T cells via downregulation of EZH2 and PI3K/AKT pathway

Luo Kewang, Ye Wei, Li Meiye, Hu Tianyong, Cheng Baohui

Journal of Ethnopharmacology · 2025

DOI: 10.1016/j.jep.2025.119802 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2025. Verfasst von Luo Kewang und 4 weiteren Autor:innen. Beteiligte Einrichtung: People's Hospital of Longhua, The Affiliated Hospital of Southern Medical University, Shenzhen, China; School of Pharmaceutical Sciences, Southern Me…. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Carcinoma, Non-Small-Cell Lung, T-Lymphocytes, Regulatory, Lung Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science, Technology and Innovation Commission of Shenzhen Municipality, National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGY REVELANCE: Huangqi Si Jun Zi decoction (HSJZ), a modified traditional Chinese medicine formula, is known to enhance immunity. However, its immunomodulatory effects in non-small cell lung cancer (NSCLC) remain poorly understood. AIM OF STUDY: This study aimed to investigate the anti-tumor potential of HSJZ in NSCLC and elucidate its mechanisms of action. MATERIAL AND METHODS: In vitro studies assessed HSJZ cytotoxicity in 4 tumor cell lines and its ability to activate immune cells from NSCLC patients, followed by evaluating the cytotoxicity of these activated immune cells against NSCLC cell lines. An orthotopic lung cancer model in mice evaluated in vivo anti-tumor activity. Flow cytometry, immunohistochemistry, and Western blot analysis were conducted to analyze immune cell populations, cytokine production, and protein expression levels, including Tregs, CD8+ T cells, EZH2, and PI3K/AKT signaling pathways. RESULTS: While HSJZ alone exhibited no direct cytotoxicity on NSCLC cells in vitro, it significantly enhanced immune cell-mediated killing when co-cultured with patient-derived peripheral blood mononuclear cells (PBMCs), accompanied with increased IFN-γ and TNF-α production. In vivo, HSJZ (1 g/kg) treatment in a murine orthotopic lung cancer model resulted in a 54.2 % reduction in tumor burden, as assessed by IVIS spectrum imaging. Mechanistically, HSJZ suppressed regulatory T cells (Tregs) both in vivo and in vitro, as demonstrated by decreased Treg frequency and downregulation of phosphorylated PI3K/AKT signaling in mice bearing Lewis tumor. Moreover, HSJZ significantly inhibited the expression of EZH2, an epigenetic regulator crucial for Treg differentiation. CONCLUSION: These findings provide compelling evidence that HSJZ exerts anti-tumor effects in NSCLC by modulating the immune microenvironment, particularly through the inhibition of Tregs activity, as assessed by in vitro co-culture system, in vivo mouse orthotopic Lewis cancer model, immunohistochemistry, etc. Our results support the potential clinical application of HSJZ as an adjunct therapy for NSCLC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enhancer of Zeste Homolog 2 ProteinCarcinoma, Non-Small-Cell LungT-Lymphocytes, RegulatoryLung NeoplasmsDrugs, Chinese HerbalAntineoplastic Agents, PhytogenicAnimalsHumansProto-Oncogene Proteins c-aktDown-RegulationSignal TransductionPhosphatidylinositol 3-KinasesMiceCell Line, TumorMaleFemaleXenograft Model Antitumor Assays

Stichwörter der Autor:innen

AKTEZH2Huangqi Si Jun Zi decoction (HSJZ)Non-small cell lung cancer (NSCLC)Regulatory T cells

Substanzen

Enhancer of Zeste Homolog 2 ProteinProto-Oncogene Proteins c-aktDrugs, Chinese HerbalEZH2 protein, humanPhosphatidylinositol 3-KinasesAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • People's Hospital of Longhua, The Affiliated Hospital of Southern Medical University, Shenzhen, China; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China. Electronic address: kewangluo@126.…
  • School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
  • Department of Otolaryngology, Shenzhen Longgang Otolaryngology Hospital & Shenzhen Otolaryngology Research Institute, China.
  • Department of Otolaryngology, Shenzhen Longgang Otolaryngology Hospital & Shenzhen Otolaryngology Research Institute, China. Electronic address: chengbaohui@sina.com.

Förderung

  • Science, Technology and Innovation Commission of Shenzhen Municipality
  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Kewang, L., Wei, Y., Meiye, L., Tianyong, H., & Baohui, C. (2025). The inhibitory effects of modified HSJZ decoction on NSCLC by regulating regulatory T cells via downregulation of EZH2 and PI3K/AKT pathway. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2025.119802

Vancouver

Kewang L, Wei Y, Meiye L, Tianyong H, Baohui C. The inhibitory effects of modified HSJZ decoction on NSCLC by regulating regulatory T cells via downregulation of EZH2 and PI3K/AKT pathway. Journal of Ethnopharmacology. 2025. doi:10.1016/j.jep.2025.119802

BibTeX
@article{Kewang2025,
  author = {Kewang, Luo and Wei, Ye and Meiye, Li and Tianyong, Hu and Baohui, Cheng},
  title = {The inhibitory effects of modified HSJZ decoction on NSCLC by regulating regulatory T cells via downregulation of EZH2 and PI3K/AKT pathway},
  journal = {Journal of Ethnopharmacology},
  year = {2025},
  doi = {10.1016/j.jep.2025.119802}
}
Kostenlos starten →